SCHEMBL845371

SCHEMBL845371

CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3NCc3ccccc3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 2/20 0.44
USP2 O75604 1/20 0.44
NPC1 O15118 1/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PABPC1 P11940 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845682 0.95 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL845027 0.89 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL874311 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL845376 0.85 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4EUSP2
SCHEMBL845189 0.83 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL845350 0.83 MAPK1 (0.49) ALDH1A1LMNAGAAMAPK1CYP2C9
SCHEMBL13272423 0.83 GAA (0.43) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL845043 0.82 ALDH1A1 (0.47) ALDH1A1LMNAGAAMAPK1CYP2C9
SCHEMBL845337 0.82 GAA (0.45) ALDH1A1LMNAGAAKDM4EMAPK1
SCHEMBL845154 0.81 ALDH1A1 (0.54) ALDH1A1LMNAKDM4EMAPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed